February 21, 2020 Upcoming events – Filgotinib's ulcerative colitis data and serlopitant takes on pruritus Gilead and Galapagos's filgotinib might not be a match for Rinvoq in ulcerative colitis, while Menlo needs to prove serlopitant works after previous setbacks.
September 27, 2019 Go or no go? Novartis eyes a big new growth driver The biggest approval decision in October will involve Novartis’s eye asset Beovu, while Biogen and Alkermes face a key verdict in MS.
